Clinical Trials Logo

Spondylitis clinical trials

View clinical trials related to Spondylitis.

Filter by:

NCT ID: NCT06273306 Not yet recruiting - Clinical trials for Arthritis, Rheumatoid

Towards Telemonitoring in Immune-Mediated Inflammatory Diseases: Implementation of a Mixed Attention Model (IMIDOC)

IMIDOC
Start date: March 15, 2024
Phase: N/A
Study type: Interventional

The main objective is to evaluate the implementation of a hybrid care model called the mixed attention model (MAM) in clinical practice and to evaluate whether its implementation improves clinical outcomes compared to conventional follow-up. This is a multicenter prospective observational study involving 360 patients with rheumatoid arthritis (RA) and Spondylarthritis (SpA) from five Spanish Hospitals. Patients will be followed-up by the MAM protocol, which is a care model that incorporates the use of digital tool consisting of a mobile application (App) that patients can use at home and that professionals can review asynchronously to detect incidents and to follow their patients; clinical evolution between face-to-face visits. Another group of patients, whose follow-up will be conducted in accordance with a traditional face-to-face care model, will be assessed as the control group. Sociodemographic characteristics, treatments, laboratory parameters, assessment of tender and swollen joints, visual analogue scale for pain and electronic patient reported outcome reports (ePROs) will be collected for all subjects. In the MAM group, these items will be self-assessed both by the mobile App and during face-to-face visits with rheumatologist, who will do the same for patients included in the traditional care model. Patients will be able to report any incidence related to their disease or treatment through the mobile App.

NCT ID: NCT06261931 Not yet recruiting - Spondyloarthritis Clinical Trials

Severity Over Time of Early Forms of Spondyloarthritis

STAR
Start date: February 12, 2024
Phase:
Study type: Observational

Spondyloarthritis (SpA) is a group of chronic inflammatory pathologies whose progression over time is poorly defined, and in particular the clinical and instrumental elements that can predispose to a condition of disease severity are not completely known. It would be important to have an idea of what the predisposing factors are, possibly already at baseline, and possibly also at follow up, of severe disease, so as to be able to act early with more aggressive and targeted therapies on these patients, so as to achieve remission.

NCT ID: NCT06259890 Recruiting - Clinical trials for Arthritis, Psoriatic

Influence of Sodium Intake in spondyLoarthriTes

SALT
Start date: January 30, 2024
Phase: N/A
Study type: Interventional

The aim of the SALT study is to analyze the relationship between dietary sodium intake and disease activity in patients with axial spondyloarthritis (radiographic or non-radiographic) or psoriatic arthritis.

NCT ID: NCT06252064 Completed - Spondyloarthropathy Clinical Trials

Rehabilitative Therapy and Pridinol in Patients With Lumbar Spondylarthrosis and Chronic Low Back Pain

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

Spondyloarthrosis is a degenerative disease involving the intervertebral disc, vertebral bodies, and adjacent soft tissues. Treatment aims to slow disease progression and manage symptoms through an interdisciplinary approach.It can be conservative, pharmacological and interventional, rarely chirurgic. This study aimed to evaluate the effectiveness of a rehabilitation program combined with Pridinol Mesylate in the treatment of Spondyloarthrosis in elderly patients in terms of pain resolution, improving disability, and quality of life versus single treatment. A randomized controlled trial was conducted in patients with spondyloarthritis. The patients recruited were divided into three groups: the Combined Group (CG), who received a rehabilitation program combined with Pridinol Mesylate; the Rehabilitation Group (RG), who received only the same rehabilitation program; and the Drug Group (DG), who received only the administration of the drug.

NCT ID: NCT06250062 Recruiting - Clinical trials for Ankylosing Spondylitis

A Clinical Study of JS005 in Patients With Ankylosing Spondylitis

Start date: January 12, 2024
Phase: Phase 2
Study type: Interventional

This is a multicentre, randomized, double-blind, parallel, placebo-controlled Phase II clinical study of 261 adults with active ankylosing spondylitis to evaluate the efficacy and safety of JS005 in the treatment of active ankylosing spondylitis.

NCT ID: NCT06242652 Not yet recruiting - Clinical trials for Ankylosing Spondylitis

A Study to Evaluate 608 in Patients With Ankylosing Spondylitis (AS)

Start date: March 19, 2024
Phase: Phase 2
Study type: Interventional

This study will evaluate the effect and safety of 608 in patients with AS.

NCT ID: NCT06230952 Recruiting - Clinical trials for Axial Spondyloarthritis

Reliability of BASDAI and BASFI Applied by Tele-Assessment Method in Axial SpA Spondyloarthritis

Start date: February 8, 2024
Phase:
Study type: Observational

The goal of this observational study is to investigate the reliability of BASDAI and BASFI questionnaires applied via tele-assessment in axial spondyloarthritis patients.

NCT ID: NCT06226792 Completed - Clinical trials for Ankylosing Spondylitis

Muscle Architecture in Ankylosing Spondylitis

Start date: January 18, 2024
Phase:
Study type: Observational [Patient Registry]

The goal of this observational study is to determine whether there is a decrease in muscle mass and the relationship between lower extremity skeletal muscle mass, muscle strength and disease activity in Ankylosing spondylitis. The main questions it aims to answer are: - Is there a relationship between the muscle thickness and pennation angle of the quadriceps, Gastrocnemius medialis and lateralis, Vastus medialis and lateralis and tibialis anterior muscles with disease activity and muscle strength? - Are there any differences in the results of morphological parameters of lower extremity muscles between Ankylosing spondylitis and voluntary participants? Researchers will compare voluntary participants to see if any difference in lower muscle morphological parameters.

NCT ID: NCT06222671 Not yet recruiting - Clinical trials for Axial Spondyloarthritis

A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)

Start date: January 31, 2024
Phase: Phase 2
Study type: Interventional

This study will evaluate the effect and safety of 608 in patients with nr-axSpA.

NCT ID: NCT06220500 Recruiting - Clinical trials for Brucella Spondylitis

Radiomics Analysis Based on MRI to Detect Brucella Spondylitis

Start date: January 1, 2023
Phase:
Study type: Observational

Brucella spondylitis, an infectious spinal disease caused by the invasion of Brucella bacteria into the body. Its diagnosis relies mainly on laboratory and imaging tests. Due to the limited diagnostic ability of X-ray and CT for Brucella spondylitis, MRI has become the main diagnostic tool. In recent years, functional magnetic resonance technology has demonstrated great advantages in the diagnosis and therapeutic evaluation of brucellosis spondylitis, which can provide pathophysiologic information about the disease and is also a noninvasive and noninvasive diagnostic tool with a broader application prospect. Radiomics, an emerging approach, has also shown better diagnostic efficacy for this disease.